2-Chloro-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol → HCID 178467112, compound

HRID 2271966Notes

Reaction equation

HRID 2271966 reaction equation
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12](=[O:14])[CH3:13])=[C:5]2[NH:15][C@H:16]1[CH2:21][CH2:20][C@H:19]([N:22]([CH3:24])[CH3:23])[CH2:18][CH2:17]1.[Cl:25][C:26]1[CH:31]=[C:30](B2OC(C)(C)C(C)(C)O2)[CH:29]=[C:28]([F:41])[C:27]=1[OH:42]>>[Cl:25][C:26]1[CH:31]=[C:30]([C:2]2[CH:3]=[C:4]3[C:9](=[CH:10][CH:11]=2)[N:8]=[CH:7][C:6]([C:12](=[O:14])[CH3:13])=[C:5]3[NH:15][C@H:16]2[CH2:21][CH2:20][C@H:19]([N:22]([CH3:24])[CH3:23])[CH2:18][CH2:17]2)[CH:29]=[C:28]([F:41])[C:27]=1[OH:42]

Participants

3

Procedure

Following general procedure F, 1-{6-bromo-4-[trans-4-(dimethylamino)cyclohexylamino]quinolin-3-yl}ethanone (30 mg, 0.077 mmol) was reacted with 2-chloro-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (42 mg, 0.154 mmol) to afford the desired product (24 mg, 68%) as a yellow-orange solid: 1H NMR (500 MHz, CD3OD+TFA-d) δ 9.13 (s, 1H), 8.48 (s, 1H), 8.29 (dd, J=8.8, 1.8 Hz, 1H), 8.00 (d, J=8.8 Hz, 1H), 7.63 (s, 1H), 7.56 (dd, J=11.4, 2.3 Hz, 1H), 4.65-4.61 (m, 1H), 3.50-3.46 (m, 1H), 2.91 (s, 6H), 2.75 (s, 3H), 2.58-2.54 (m, 2H), 2.34-2.28 (m, 2H), 1.91-1.81 (m, 4H); ESI MS m/z 456 [C25H27ClFN3O2+H]+; HPLC 97.1% (AUC), tR=9.52 min.

Sources & evidence

ORD record
ord-36c97c3550d248879af4adcbb03698a8
Source dataset
uspto-grants-2015_09
Patent number
US09120749B2

Reaction notes

Loading…